Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
60.11
-0.50 (-0.82%)
At close: Jun 9, 2026, 4:00 PM EDT
60.63
+0.52 (0.87%)
After-hours: Jun 9, 2026, 4:10 PM EDT
Monopar Therapeutics Employees
Monopar Therapeutics had 22 employees as of December 31, 2025. The number of employees increased by 6 or 37.50% compared to the previous year.
Employees
22
Change (1Y)
6
Growth (1Y)
37.50%
Revenue / Employee
n/a
Profits / Employee
-$681,135
Market Cap
402.66M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 22 | 6 | 37.50% | 22 | 0 |
| Dec 31, 2024 | 16 | 6 | 60.00% | 14 | 2 |
| Dec 31, 2023 | 10 | -2 | -16.67% | 9 | 1 |
| Dec 31, 2022 | 12 | 2 | 20.00% | 11 | 1 |
| Dec 31, 2021 | 10 | 0 | - | 9 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Adlai Nortye | 109 |
| Editas Medicine | 87 |
| Century Therapeutics | 78 |
| Upstream Bio | 75 |
| Eupraxia Pharmaceuticals | 49 |
| vTv Therapeutics | 26 |
| Forte Biosciences | 22 |
MNPR News
- 5 days ago - Monopar Therapeutics Slides: Corporate presentation - Filings
- 8 days ago - Monopar Therapeutics presents ALXN1840-WD-205 data at EASL - TheFly
- 8 days ago - Monopar Presents Phase 2 ALXN1840 Data Demonstrating Liver Disease Stabilization and Neurologic Improvement in Treatment-Experienced Wilson Disease Patients at EASL 2026 - GlobeNewsWire
- 21 days ago - Monopar Announces Publication of Phase 2 Study Demonstrating ALXN1840 Significantly Improves Copper Balance in Patients with Wilson Disease - GlobeNewsWire
- 26 days ago - Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 26 days ago - Monopar Therapeutics Quarterly report: Q1 2026 - Filings
- 26 days ago - Monopar Therapeutics Earnings release: Q1 2026 - Filings
- 5 weeks ago - Monopar Therapeutics Proxy statement: Proxy filing - Filings